Literature DB >> 21248727

CYP2D6 in the brain: impact on suicidality.

J C Stingl, R Viviani.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21248727     DOI: 10.1038/clpt.2010.239

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  11 in total

Review 1.  CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

Authors:  Eva M Peñas-Lledó; Adrián Llerena
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

2.  Sex hormones regulate cerebral drug metabolism via brain miRNAs: down-regulation of brain CYP2D by androgens reduces the analgesic effects of tramadol.

Authors:  Jie Li; Mengmeng Xie; Xiaoshuang Wang; Xiufang Ouyang; Yu Wan; Guicheng Dong; Zheqiong Yang; Jing Yang; Jiang Yue
Journal:  Br J Pharmacol       Date:  2015-08-26       Impact factor: 8.739

3.  Impact of cytochrome P450 genes on suicide attempt and risk.

Authors:  Eva M Peñas-Lledó; M Eugenia G Naranjo; Adrián Llerena
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-03-16       Impact factor: 5.270

Review 4.  Single Nucleotide Polymorphisms and the Central Nervous System: Potential Biomarkers in Identifying Suicide Risk.

Authors:  Atmaram Yarlagadda; Kevin P Rosenblatt; Anita H Clayton
Journal:  Innov Clin Neurosci       Date:  2017-06-01

5.  Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.

Authors:  Ivan Skadrić; Oliver Stojković
Journal:  Int J Legal Med       Date:  2019-12-20       Impact factor: 2.686

6.  A combined high CYP2D6-CYP2C19 metabolic capacity is associated with the severity of suicide attempt as measured by objective circumstances.

Authors:  E Peñas-Lledó; S Guillaume; M E G Naranjo; A Delgado; I Jaussent; H Blasco-Fontecilla; P Courtet; A LLerena
Journal:  Pharmacogenomics J       Date:  2014-08-12       Impact factor: 3.550

7.  A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts.

Authors:  Eva M Peñas-Lledó; Sebastien Guillaume; Fernando de Andrés; Ana Cortés-Martínez; Jonathan Dubois; Jean Pierre Kahn; Marion Leboyer; Emilie Olié; Adrián LLerena; Philippe Courtet
Journal:  Transl Psychiatry       Date:  2022-10-18       Impact factor: 7.989

8.  Cases of adverse reaction to psychotropic drugs and possible association with pharmacogenetics.

Authors:  Irina Piatkov; Trudi Jones; Mark McLean
Journal:  J Pers Med       Date:  2012-10-01

9.  Towards the clinical implementation of pharmacogenetics in bipolar disorder.

Authors:  Naji C Salloum; Michael J McCarthy; Susan G Leckband; John R Kelsoe
Journal:  BMC Med       Date:  2014-05-30       Impact factor: 8.775

10.  Decreased hippocampal volume and increased anxiety in a transgenic mouse model expressing the human CYP2C19 gene.

Authors:  A Persson; S C Sim; S Virding; N Onishchenko; G Schulte; M Ingelman-Sundberg
Journal:  Mol Psychiatry       Date:  2013-07-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.